Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1498 of 5804
-
Could sound waves help Alzheimer's drugs work better?
Disease control OngoingThe purpose of this study is to assess the safety and feasibility of administering standard of care monoclonal antibody (mAb) infusion therapy in combination with opening the blood-brain barrier with the Exablate Model 4000 Type 2 device in patients with mild Alzheimer's disease …
Phase: EARLY_PHASE1 • Sponsor: Ali Rezai • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New radiation technique aims to make stem cell transplants safer for sickle cell patients
Disease control Recruiting nowThis phase I trial tests the safety and effectiveness of total marrow and lymphoid irradiation (TMLI) and alemtuzumab as a conditioning regimen in patients with sickle cell disease. Conditioning regimens are treatments used to prepare a patient for stem cell transplantation. A st…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a natural compound help kick the vaping habit?
Disease control CompletedThis placebo-controlled Phase 2 study is being conducted at sites within the United States to evaluate the efficacy and safety profile of 3 mg cytisinicline administered TID for 12 weeks for vaping cessation.
Phase: PHASE2 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Tetris therapy for new moms: a game that could erase traumatic birth memories?
Symptom relief CompletedThis single-blind waitlist randomized controlled trial aims to investigate the efficacy of a single-session behavioral intervention composed of a brief evocation of the childbirth memory followed by a visuospatial task (the computer game "Tetris"), on childbirth-related intrusive…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New study tracks organ health after sickle cell 'Cures'
Knowledge-focused Recruiting nowSickle Cell Disease is one of the most common genetic diseases in the United States, occurring in approximately 1 in 400 births. Approximately 100,000 individuals are diagnosed with SCD in the United States. Mortality for children with SCD has decreased substantially over the pas…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Brain zaps show promise for tough schizophrenia symptoms
Symptom relief CompletedThe major target of the study is to confirm the safety and efficacy of our augmented protocol of theta-burst TMS in schizophrenia. Our aim is to confirm the beneficial effects of rTMS treatment on multiple aspects of the disorder such as (1) clinical aspect in terms of PANSS, (2)…
Phase: NA • Sponsor: Semmelweis University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New device zaps spine tumor pain in clinical trial
Symptom relief CompletedThe SPARTA study (Spinery® Radiofrequency Ablation Device Study) is a prospective, multicenter, single-arm clinical investigation designed to evaluate the safety, performance, and efficacy of the Spinery® RF Generator and its sterile single-use accessories for the palliative trea…
Phase: NA • Sponsor: Axon srl • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Novavax confirms its COVID-19 vaccine works the same across different batches
⭐️ VACCINE ⭐️ CompletedThis is a randomized, Phase 3 study comparing the immunogenicity and safety of 3 different lots of Novavax vaccine with Matrix-M™ adjuvant (NVX-CoV2373).The study will enroll approximately 900 previously vaccinated adults 18 to 49 years of age, inclusive.
Phase: PHASE3 • Sponsor: Novavax • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:09 UTC
-
New daily pill could ease ADHD symptoms in kids
Symptom relief CompletedThis trial will be conducted to evaluate the efficacy of centanafadine once daily (QD) extended release (XR) versus placebo in the treatment of child subjects (4 to 12 years, inclusive) with ADHD. The trial will consist of a screening period, a double-blind treatment period, and …
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Iron infusions may boost gut healing in celiac disease
Disease control TerminatedThe study aims is to evaluate the efficacy of intravenous iron supplementation on celiac disease remission (total intestinal mucosal recovery). This randomized multicenter trial compare the administration of intravenous iron by infusion (Ferinject©: 15 mg/kg in NaCl solution in 3…
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Endoscopic obesity treatments under 10-Year microscope
Disease control ENROLLING_BY_INVITATIONThis is a prospective collection of data from adult patients who have had an endoscopic metabolic and bariatric endoscopy procedure (EMBT) for primary or revision surgical procedures for obesity.
Sponsor: Christopher C. Thompson, MD, MSc • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Baby breathing treatment: gene test may end guesswork for albuterol in bronchiolitis
Knowledge-focused Recruiting nowBronchiolitis is the leading cause of pediatric morbidity and healthcare costs. Despite the commonplace use of bronchodilator treatments, like albuterol, in conditions like asthma, their efficacy in bronchiolitis remains controversial due to the heterogeneity in patient response.…
Phase: PHASE3 • Sponsor: Nemours Children's Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New drug cocktail targets rare eye cancer
Disease control OngoingBecause we suspect that the benefit of anti-PD-1 in metastatic UM patients could vary according to previous exposure to Tebentafusp (better efficacy of anti-PD-1 after Tebentafusp), the combination of pembrolizumab and lenvatinib will be assessed in two independent cohorts: cohor…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New Steroid-Like drug tested for muscle disease
Disease control CompletedThis Phase II pilot study is a randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, PK, PD, and exploratory clinical efficacy of vamorolone 500mg (250mg for body weight \<50 kg) daily administered orally compared to placebo over a treatment per…
Phase: PHASE2 • Sponsor: ReveraGen BioPharma, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:34 UTC
-
New drug cocktail targets Hard-to-Treat bladder cancer
Disease control OngoingThis phase Ib trial evaluates the best dose, potential benefits, and/or side effects of erdafitinib in combination with enfortumab vedotin in treating patients with bladder cancer that has spread from where it first started (primary site) to other places in the body (metastatic) …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Automated insulin pump takes on type 1 diabetes in Head-to-Head trial
Disease control CompletedSubject will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 90-day outpatient phase where subjects will either use the Omnipod 5 system or continue to use their personal insulin pump with the …
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 26, 2026 18:22 UTC
-
Magic mushroom therapy takes on meth addiction in veterans
Disease control OngoingThis is a proof-of-concept randomized clinical trial of psilocybin-enhanced psychotherapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.
Phase: PHASE1, PHASE2 • Sponsor: Portland VA Research Foundation, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immunotherapy combo may delay progression in advanced bladder cancer
Disease control CompletedImmunotherapy has improved clinical outcomes in metastatic urothelial carcinoma (mUC). Second-line treatment after progression to platinum-containing chemotherapy with immune checkpoint inhibitors (ICIs) have antitumor activity in advanced / metastatic UC and provide favorable sa…
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill shows promise for Hard-to-Treat cancers with BRAF mutation
Disease control Recruiting nowThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other study medicines in people with solid tumors. This study is seeking participants who have an advance…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Spinal implant offers new hope for diabetic leg pain
Symptom relief OngoingThe purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study,…
Phase: NA • Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC